About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed SEPSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALIZAPRIDE reported SEPSIS to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and SEPSIS. In doing so, we compare ALIZAPRIDE with other drugs that cause SEPSIS, to help you evaluate whether or not ALIZAPRIDE causes SEPSIS. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if SEPSIS ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing SEPSIS: 1
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where SEPSIS is a reported side effect: 0.9804%

FDA reports of any drug causing SEPSIS : 37701
Average percentage for all medicated patients where SEPSIS is reported as a complication: 0.2363%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with SEPSIS:

HEPARIN SODIUM INJECTION (4870 patients)
ASPIRIN (2809 patients)
METHOTREXATE (2492 patients)
PREDNISOLONE (2455 patients)
PREDNISONE (2336 patients)
REVLIMID (2034 patients)
LASIX (1956 patients)
DIANEAL (1901 patients)
REMICADE (1864 patients)
DEXAMETHASONE (1686 patients)
CYCLOPHOSPHAMIDE (1670 patients)
FUROSEMIDE (1543 patients)
HUMIRA (1519 patients)
OMEPRAZOLE (1421 patients)
FOLIC ACID (1361 patients)
ACETAMINOPHEN (1354 patients)
CYCLOSPORINE (1192 patients)
ALLOPURINOL (1142 patients)
CYTARABINE (1125 patients)
FOSAMAX (1097 patients)
VANCOMYCIN (1038 patients)
LISINOPRIL (1025 patients)
FLUOROURACIL (1015 patients)
ZOMETA (996 patients)
POTASSIUM CHLORIDE (989 patients)
NEXIUM (957 patients)
CISPLATIN (956 patients)
PREDNISONE TAB (941 patients)
SIMVASTATIN (934 patients)
DIGOXIN (927 patients)
LIPITOR (897 patients)
VIOXX (892 patients)
COUMADIN (890 patients)
AVONEX (853 patients)
MYCOPHENOLATE MOFETIL (848 patients)
ETOPOSIDE (845 patients)
CARBOPLATIN (798 patients)
PROTONIX (783 patients)
EXJADE (782 patients)
FLUCONAZOLE (776 patients)
MORPHINE (771 patients)
ALBUTEROL (755 patients)
ENBREL (755 patients)
TACROLIMUS (753 patients)
DOXORUBICIN HCL (750 patients)
OXYCONTIN (745 patients)
ZOFRAN (739 patients)
DECADRON (732 patients)
PROGRAF (720 patients)
NORVASC (712 patients)
VINCRISTINE (709 patients)
VELCADE (704 patients)
CIPROFLOXACIN (702 patients)
PLAVIX (687 patients)
NEORAL (684 patients)
ATIVAN (676 patients)
ACYCLOVIR (674 patients)
INSULIN (670 patients)
WARFARIN SODIUM (663 patients)
RITUXIMAB (662 patients)
ATENOLOL (659 patients)
TYSABRI (646 patients)
NEURONTIN (641 patients)
METHYLPREDNISOLONE (639 patients)
SYNTHROID (634 patients)
PRILOSEC (634 patients)
HEPARIN (630 patients)
NEUPOGEN (623 patients)
LANSOPRAZOLE (616 patients)
AMBIEN (604 patients)
LEVOTHYROXINE SODIUM (599 patients)
LEVAQUIN (595 patients)
LORAZEPAM (592 patients)
HEPARIN SODIUM (591 patients)
METOPROLOL TARTRATE (583 patients)
AMLODIPINE (582 patients)
IBUPROFEN (571 patients)
METFORMIN HCL (560 patients)
VIDAZA (560 patients)
FAMOTIDINE (558 patients)
HYDROCHLOROTHIAZIDE (551 patients)
FENTANYL (538 patients)
GABAPENTIN (533 patients)
LANTUS (526 patients)
DIFLUCAN (525 patients)
OXALIPLATIN (517 patients)
VICODIN (515 patients)
PANTOPRAZOLE (502 patients)
AREDIA (501 patients)
SOLU-MEDROL (494 patients)
ZOCOR (492 patients)
GOLIMUMAB (490 patients)
SOLIRIS (476 patients)
XANAX (476 patients)
EXTRANEAL (476 patients)
PAXIL (469 patients)
OXYCODONE HCL (461 patients)
TOPROL-XL (457 patients)
BACTRIM (453 patients)
ZOLOFT (452 patients)
PERCOCET (446 patients)
LOVENOX (445 patients)
THALOMID (445 patients)
RAMIPRIL (445 patients)
AVASTIN (439 patients)
MULTI-VITAMINS (436 patients)
METOCLOPRAMIDE (435 patients)
DOCETAXEL (435 patients)
VITAMIN D (432 patients)
BEVACIZUMAB (431 patients)
CAPECITABINE (430 patients)
LYRICA (425 patients)
AZATHIOPRINE (424 patients)
COREG (421 patients)
MEROPENEM (420 patients)
FLAGYL (419 patients)
PREDONINE (416 patients)
TRACLEER (412 patients)
PREVACID (407 patients)
TRAMADOL HCL (407 patients)
LACTULOSE (397 patients)
REGLAN (391 patients)
SPIRONOLACTONE (391 patients)
LEUCOVORIN CALCIUM (391 patients)
PARACETAMOL (386 patients)
XELODA (386 patients)
LEVOFLOXACIN (385 patients)
CELLCEPT (382 patients)
METRONIDAZOLE (382 patients)
NITROGLYCERIN (381 patients)
DIOVAN (378 patients)
HYDROCORTISONE (376 patients)
CLOZARIL (371 patients)
CELEBREX (370 patients)
VOLTAREN (370 patients)
ARANESP (370 patients)
TAXOTERE (369 patients)
EPOGEN (363 patients)
FORTEO (361 patients)
SEROQUEL (359 patients)
MYLOTARG (357 patients)
METOPROLOL (355 patients)
CALCIUM (355 patients)
THALIDOMIDE (354 patients)
DILAUDID (354 patients)
COLACE (353 patients)
ADVAIR DISKUS 100/50 (353 patients)
MAGNESIUM OXIDE (351 patients)
PACLITAXEL (351 patients)
ONDANSETRON (349 patients)
COMPAZINE (348 patients)
ROCEPHIN (340 patients)
RANITIDINE (338 patients)
LORTAB (336 patients)
VITAMIN B-12 (334 patients)
CLONAZEPAM (333 patients)
HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% (333 patients)
NYSTATIN (332 patients)
PEPCID (329 patients)
AMOXICILLIN (328 patients)
SPIRIVA (328 patients)
CALCIUM CARBONATE (327 patients)
MORPHINE SULFATE (326 patients)
ZOSYN (326 patients)
ALPRAZOLAM (324 patients)
DEXAMETHASONE TAB (324 patients)
ZANTAC (324 patients)
PANTOPRAZOLE SODIUM (320 patients)
LOPRESSOR (319 patients)
FERROUS SULFATE TAB (318 patients)
LEXAPRO (314 patients)
ENALAPRIL MALEATE (312 patients)
FLOMAX (312 patients)
BENADRYL (312 patients)
REBIF (311 patients)
CYMBALTA (311 patients)
ALDACTONE (308 patients)
TYLENOL (307 patients)
GLEEVEC (306 patients)
TOCILIZUMAB (304 patients)
CETUXIMAB (302 patients)
FLUDARABINE PHOSPHATE (301 patients)
CRESTOR (298 patients)
MULTI-VITAMIN (297 patients)
FLUDARA (292 patients)
SINGULAIR (291 patients)
ENOXAPARIN SODIUM (290 patients)
ALBUMIN (HUMAN) (287 patients)
GLIPIZIDE (285 patients)
SANDOSTATIN LAR (285 patients)
KYTRIL (283 patients)
ASCORBIC ACID (283 patients)
RIBAVIRIN (283 patients)
THYMOGLOBULIN (282 patients)
NPLATE (281 patients)
SODIUM CHLORIDE (279 patients)
NEULASTA (279 patients)
TYLENOL (CAPLET) (278 patients)
MABTHERA (276 patients)
DAUNORUBICIN HCL (276 patients)
IRON (275 patients)
AUGMENTIN '125' (274 patients)
GLYBURIDE (273 patients)
CLOZAPINE (272 patients)
CARVEDILOL (270 patients)
TAXOL (269 patients)
NEXAVAR (266 patients)
DIAZEPAM (263 patients)
MS CONTIN (261 patients)
ATROVENT (261 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about SEPSIS and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Elwood Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use